Nektar Therapeutics (NKTR) Other Gross PP&E Adjustments: 2010-2025
Historic Other Gross PP&E Adjustments for Nektar Therapeutics (NKTR) over the last 7 years, with Sep 2025 value amounting to -$7.2 million.
- Nektar Therapeutics' Other Gross PP&E Adjustments rose 20.00% to -$7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.0 million, marking a year-over-year increase of 31.40%. This contributed to the annual value of -$28.3 million for FY2024, which is 25.96% up from last year.
- Per Nektar Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$7.2 million for Q3 2025, which was up 5.46% from -$7.6 million recorded in Q2 2025.
- In the past 5 years, Nektar Therapeutics' Other Gross PP&E Adjustments registered a high of $110.4 million during Q2 2022, and its lowest value of -$125.0 million during Q1 2021.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$17.3 million (2024), whereas its average is -$19.7 million.
- Data for Nektar Therapeutics' Other Gross PP&E Adjustments shows a peak YoY increase of 190.18% (in 2022) and a maximum YoY decrease of 278.29% (in 2022) over the last 5 years.
- Over the past 5 years, Nektar Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $43.8 million in 2021, then slumped by 278.29% to -$78.1 million in 2022, then soared by 51.08% to -$38.2 million in 2023, then rose by 25.96% to -$28.3 million in 2024, then increased by 20.00% to -$7.2 million in 2025.
- Its Other Gross PP&E Adjustments was -$7.2 million in Q3 2025, compared to -$7.6 million in Q2 2025 and -$8.0 million in Q1 2025.